| 发明名称 |
Treatment of cancer using GFR alpha-4 chimeric antigen receptor |
| 摘要 |
The present disclosure relates to compositions and methods for treating diseases, disorders or conditions associated with the expression of the Glycosyl-phosphatidylinositol (GPI)-linked GDNF family a-receptor 4 (GFRa4). |
| 申请公布号 |
AU2015301460(A1) |
申请公布日期 |
2017.03.23 |
| 申请号 |
AU20150301460 |
申请日期 |
2015.08.14 |
| 申请人 |
The Trustees of the University of Pennsylvania;Novartis AG |
发明人 |
Siegel, Donald;Milone, Michael;Bhoj, Vijay |
| 分类号 |
C07K16/28;A61K35/17;A61K39/395;A61P35/00;C07K14/705;C07K14/725;C07K16/30 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
